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An Interleukin-2 Signal Relieves
BSAP (Pax5)-Mediated Repression
of the Immunoglobulin J Chain Gene
Julie L. Rinkenberger,* Jeffrey J. Wallin, major control sequence within this region has been de-
fined by a combination of deletion and linked promoterKirk W. Johnson,† and Marian Elliott Koshland
analyses (Lansford et al., 1992; Shin and Koshland,Immunology Division
1993). Assays for loss of function in J chain–expressingDepartment of Molecular and Cell Biology
plasmacytomas revealed two adjacent positive regula-University of California, Berkeley
tory elements: a T-rich sequence (270 to 257) denotedBerkeley, California 94720
JA and a second purine-rich sequence (256 to 245)
denoted JB. The JB activity has been shown to be medi-
ated by PU.1, a B cell– and macrophage-specific tran-Summary
scription factor belonging to the Ets oncoprotein family
(Klemsz et al., 1990; Shin and Koshland, 1993). The fac-Cytokine regulation of B cell development was ana-
tor responsible for JA function has yet to be positivelylyzed using interleukin-2 (IL-2)-induced transcription
identified. The contribution of each element was estab-of the J chain gene as a model system. A nuclear
lished by mutational analyses; base changes that pre-target of the IL-2 signal was identified as the Pax5
vented either NF-JA or PU.1 binding resulted in a 95%transcription factor, BSAP, which recognizes a nega-
loss of promoter activity (Lansford et al., 1992; Shin andtive regulatory motif in the J chain promoter. Func-
Koshland, 1993; S. Karray and M. E. K., unpublishedtional assays showed that BSAP mediates the silenc-
data).ing of the J chain gene during the early stages of B
In the studies reported here, we used assays for gaincell development, but repression is relieved during the
of function in J chain–silent lymphomas to locate a nega-antigen-driven stages in a concentration-dependent
tive regulatory element, JC, upstream of the JA and JBmanner by an IL-2-induced down-regulation of BSAP
elements. Its activity was found to be mediated by theRNA expression. At the low levels present in J chain–
transcription factor, B cell lineage-specific activator pro-expressing plasma cells, BSAP repression could be
tein (BSAP), a 50 kDa protein that binds DNA as a mono-overridden by positive-acting factors binding to down-
mer (Adams et al., 1992). BSAP is a product of the Pax5stream J chain promoter elements. Overexpression of
gene, a member of a family of developmental controlBSAP in these cells reversed the positive regulation
genes that encode transcription factors containing aand inhibited J chain gene transcription. Thus, IL-2
paired DNA-binding domain. The nine mammalian Paxregulation of BSAP concentration may provide a
genes identified so far are transcribed primarily in themechanism for controlling both repressor and activa-
embryo and have been assigned important functions intor functions of BSAP during a B cell immune re-
the developing central nervous system based on theirsponse.
expression patterns and mutational phenotypes (Stra-
chan and Read, 1994). In addition to its role in midbrain
Introduction patterning, the Pax5 gene isexpressed in the B lymphoid
lineage and has been shown to function throughout B
The J chain gene is one of the few identified nuclear cell development (Busslinger and Urbanek, 1995; Neu-
targets of interleukin-2 (IL-2) signaling. Its expression is rath et al.,1995b; Michaelson et al., 1996). Thus, targeted
initiated late in a primary immune response when the disruption of the mouse Pax5 gene has established that
IL-2 secreted by antigen-activated T helper cells binds BSAP expression is critical in early B lymphopoiesis
to high affinity IL-2 receptors expressed on antigen- (Urbanek et al., 1994). The mutant mice exhibited a block
activated B cells (Nakanishi et al., 1984; Matsui et al., at a precursor stage and failed to produce pre-B, B,
1989). The signal generated is then delivered to the pro- and plasma cells of the conventional or CD5 lineage.
moter of the J chain gene, where it induces a nuclease Moreover, BSAP-binding sites have been located in the
hypersensitive region (Minie and Koshland, 1986) and promoter regions of a number of B cell–specific genes
activates synthesis of the J protein required for assem- and shown by transient transfection analyses to activate
bly of pentamer immunoglobulin M (IgM) antibody (Niles transcription; these include the genes encoding the
et al., 1995). Since these events can be reproduced in pre-B cell signaling molecules, Vpre-B and l5 (Okabe et
vitro in the IL-2-responsive BCL1 cell line (Blackman et al., 1992; Yang et al., 1995), as well as genes encoding
al., 1986; Brooks et al., 1983), expression of the J chain molecules associated with antigen receptor signaling,
gene provides a useful model system for analyzing how the CD19 coreceptor (Kozmik et al., 1992; Kehrl et al.,
cytokine-generated signals regulate genes involved in 1994), and the Blk Src kinase (Zwollo and Desiderio,
differentiative events. 1994). Finally, in the antigen-driven stages of B cell dif-
The region of the J chain promoter that becomes hy- ferentiation, BSAP has been shown to up-regulate B cell
persensitive upon IL-2 signaling extends approximately proliferation (Wakatsuki et al., 1994), to be required for
2170 bp upstream of the transcriptional start site. A germline e transcription that precedes an IgE switch
(Liao et al., 1994), and to be relieved of its activity as a
repressor of the 39 heavy chain enhancer, 39aE(hs1,2)*Present address: Washington University School of Medicine, 660
(Singh and Birshtein, 1993; Neurath et al., 1994).South Euclid Avenue, St. Louis, Missouri 63110.
In this report, we identify BSAP as one of the factors†Present address: Chiron Corporation, 4560 Horton Street, Em-
eryville, California 94608. responsible for the tight transcriptional control of the
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cell line PD31 and assayed for CAT activity (Figure 1A).
The analyses showed that the intact J promoter was only
minimally active in PD31 cells, the absolute percentage
conversionof chloramphenicol to acetylated forms aver-
aging .026 per microgram of protein per 0.1 mCi of
[14C]chloramphenicol, 0.4% of the activity of the same
construct in the J chain–expressing S194 plasmacytoma
cells (Lansford et al., 1992). Nevertheless, examination
of the various deletion constructs indicated that a nega-
tive regulatory element, denoted JC, was located in the
59 distal portion of the hypersensitive site, upstream of
the already defined JA and JB motifs (Figure 1B). Thus,
deletion of base pairs 2136 to 2108 produced a 3-fold
increase in CAT activity over that of the intact promoter.
Further deletion of the positive-acting JA and JB ele-
ments, located between base pairs 276 and 245, re-
sulted in a 6-fold drop in CAT activity as previously
reported (Lansford et al., 1992).
Characterization of a Nuclear Factor Interacting
with the JC Repressor Element
Factor binding to the JC element was examined by gel
mobility shift assays using a J2 probe encoding base
pairs 2168 to 284 (Figure 1B) and nuclear extracts fromFigure 1. Effect of Deletions on the Promoter Activity of the J Chain
B cell and plasmacytoma lines representing successiveGene 59 Flanking Region
stages in B cell development (Figure 2A). Of the several(A) Identification of a negative regulatory element. Deletion con-
retained bands obtained, only the predominant, moststructs were transfected into J chain–silent PD31 pre-B cells and
compared for CAT activity with the reference construct. Mean per- rapidly migrating one exhibited a pattern consistent with
centages of CAT conversion (6SEM) were calculated from the aver- our previous finding (McFadden and Koshland, 1991)
age values of at least three independent, duplicate determinations. that NF-JC binding to the JC element correlates in-
(B) Schematic diagram of the 59 flanking region of the murine J chain
versely with J chain gene transcription (Figure 2A). Largegene showing the location of the negative regulatory element, JC,
amounts of complex were formed with extracts from Jrelative to the nuclease hypersensitive site, marker restriction en-
chain–silent cells, the PD31 pre-B line, the K46R maturezyme sites, binding sites for other regulatory factors, and probes
specific for JC and JA–JB sites. B cell line, and the BCL1 presecretor line. The amount
was reduced approximately one half in extracts from
BCL1 cells induced by IL-2 to express J chain and further
immunoglobulin J chain gene. We present evidence that reduced in extracts from CH12LX cells that constitu-
BSAP mediates the silencing of the J chain gene during tively express low levels of J chain (Randall et al., 1992;
the early stages of B cell development and is relieved Niles et al., 1995). Finally, the complex was just detect-
of that function during the antigen-driven stage by, first, able in extracts from S194 plasmacytoma cells that con-
an IL-2-induced down-regulation of BSAP RNA expres- tain high levels of J chain (Koshland, 1985). The gel
sion and, second, the overriding effects of positive-act- mobility shift assays also indicated that NF-JC binding
ing factors, NF-JA and PU.1, binding to other promoter is B cell specific. As the binding pattern of extract from
motifs. The demonstration that BSAP can block gene the T cell hybridoma BO4H illustrates (Figure 2A), no
transcription directly by binding to an inherently repres- complexes with the mobility or specificity of NF-JC were
sive promoter site adds yet another function to its reper- observed when nuclear extracts from the T cell lines
toire and thus strengthens its assignment as a key regu- EL-4 and CTLL, from the fibroblast line L929, and from
lator of B cell differentiation. human HeLa cells were incubated with the J2 probe
(data not shown).
The JC element was first localized by gel mobility shiftResults
assays using J2 probes successively deleted at the 39
end (Figure 2B). Removal of the 39 14 bp (2168 to 297)Identification of the JC Element
by Deletion Analyses did not detectably alter NF-JC binding compared with
that obtained with the wild-type J2 probe. However,The constructs used for deletion analyses of the J chain
promoter have been described previously (Lansford et removal of an additional 16 bp (2168 to 2113) com-
pletely abrogated NF-JC complex formation, suggestingal., 1992). They contained a series of 59 truncated se-
quences from the hypersensitive region (Figure 1A) that that base pairs 2113 to 297 are essential for NF-JC
binding. The results of the gel mobility shift assays werewere inserted upstream of the chloramphenicol acetyl-
transferase (CAT) gene and a 1 kb sequence of heavy confirmed by methylation protection footprinting of the
complex formed with the J2 probe (Figure 3A). The NF-chain intron enhancer. To identify elements that re-
pressed J chain gene transcription, these various con- JC-retained band gave a long, staggered footprint ex-
tending from base pair 2126 through the SphI site (2118structs were transfected into the J chain–silent pre-B
BSAP Repression of the J Chain Gene
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Figure 3. Dimethylsulfate Methylation Protection Analyses of NF-
JC Binding
(A) Methylation protection patterns obtained on the coding strand
(right) and noncoding strand (left) of the J2 promoter probe (2168
to 284) after reaction with nuclear extract from the J chain negative
B cell lymphoma K46R. B, bound reaction; F, free reaction; G/A,
cleavage at guanines and adenines. The NF-JC footprint is dia-
grammed below; boxes indicate protected residues, and asterisks
indicate residues hypersensitive to cleavage.
(B) Comparison of the NF-JC footprint with the consensus BSAP
recognition site determined by Czerny et al. (1993).
Figure 2. Gel Mobility Shift Analyses of the Binding of the Nuclear
Factor, NF-JC, to the JC Element in the J Chain Gene Promoter
of the BSAP-paired DNA-binding domain and that the
(A) NF-JC expression at successive stages of B cell development. overall affinity of a given BSAP-binding site depends on
For the binding reactions, labeled J2 probe was incubated either
the strength of interaction at each half site. This typealone or with extracts from the PD31 pre-B cell line, the mature B
of interaction allows for considerable variation in thecell line K46R, the BCL1 presecretor line untreated or treated for 3
days with 100 U/ml of IL-2, the CH12LX presecretor line, the S194 sequences recognized by BSAP, since base changes
plasmacytoma cell line, and the T cell hybridoma BO4H. in one half site that decrease binding affinity can be
(B) Localization of NF-JC-binding site. For the binding reactions, compensated by base changes in the other half site
labeled J2 probes successively deleted at the 39 end were incubated
that increase binding affinity. As a result, none of theeither alone or with nuclear extract from the mature B cell line K46R.
naturally occurring BSAP-binding sites, including the JC
motif, completely conforms to the consensus sequence.
The homology in the sequences recognized by NF-JCto 2113) to base pair 2111. The protected bases were
located on the noncoding strand in the 59 half of the and BSAP and their B cell–specific expression patterns
suggested that the two factors might be identical. Tofootprint and on both strands in the 39 half comprising
the SphI site. In addition, nucleotides hypersensitive to obtain direct experimental evidence, we compared their
DNA binding properties. Gel mobility shift assaysmethylation were located at positions 2111, 2113, and
2118 on the coding strand and at position 2117 on the showed that in vitro synthesized BSAP bound strongly
to the JC oligonucleotide, and the resulting complexnoncoding strand.
had the same mobility on a polyacrylamide gel as the
complex formed with endogenously produced NF-JCIdentification of NF-JC as the Pax5 Gene
Product, BSAP protein (Figure 4A). Furthermore, both BSAP and NF-JC
complexes were inhibited by a 100-fold molar excessA search of previously identified factor-binding sites in
B lymphocyte genes revealed a considerable homology of the classical BSAP recognition sequence from the
histone H2A-2.2 gene promoter (Czerny et al., 1993),between the sequence recognized by NF-JC and those
recognized by the BSAP product of the Pax5 gene (Fig- whereas neither complex was inhibited by a 100-fold
molar excess of a mutant JC oligonucleotide, eitherure 3B). By aligning various BSAP-binding sites, Czerny
et al. (1993) have defined a consensus sequence con- JCM1 or JCM2, containing a 4 bp substitution that abro-
gated NF-JC binding (Figure 4B). Finally, gel mobilitysisting of 59 and 39 half sites. Their studies have shown
that two half sites are recognized by two subregions shift assays showed that rabbit antisera against the
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Figure 5. IL-2-Induced Decrease in BSAP RNA Levels
Top two frames, Southern blots of RT–PCR BSAP and tubulin cDNA
from BCL1 cells cultured in the presence and absence of 100 U/ml
of IL-2. Bottom frame, Western blots of the BSAP content in nuclear
extracts prepared from BCL1 cells cultured as described above.
ing to the JC element in the J chain promoter (McFadden
and Koshland, 1991). To determine whether the reduced
binding reflected a decrease in BSAP synthesis, we
extracted RNA from BCL1 cells at intervals after IL-2
stimulation and determined the BSAP content by re-
verse transcription–polymerase chain reaction (RT–
PCR). Two BSAP-specific products were observed (Fig-
ure 5) whether the RNA was extracted from untreated
or IL-2-treated cells and whether the primers used gen-
erated full-length BSAP cDNA (Adams et al., 1992) or
the amino-terminal two thirds. Comparison with size
standards indicated that the more slowly migrating form
had the size expected for a full-length cDNA, whereasFigure 4. Identification of NF-JC as the BSAP Product of the Pax5
the faster migrating form was approximately 150 bpGene
shorter. Comparison of restriction enzyme digestion(A) Comparison of the binding specificities of NF-JC and BSAP. Gel
patterns located the base pairs missing from the shortermobility shift assays of the binding of K46R nuclear extract and in
vitro synthesized BSAP to the JC oligonucleotide in the absence or cDNA to the 59 290 bp of BSAP coding sequence. From
presence of a 100-fold molar excessof histoneH2A-2.2 oligonucleo- the size and position of the deletion it seemed likely that
tide (Czerny et al., 1993), M1 mutant JC oligonucleotide, or M2 the shorter cDNA species represented a BSAP isoform
mutant JC oligonucleotide. The sequences of the wild-type JC, the
lacking exon 2 (base pairs 51 to 213) (Urbanek et al.,H2A 2.2 histone,and the mutant M1 and M2 JC oligomers are shown
1994). Exon 2 encodes the amino-terminal half of thebelow; the substitutions made in the NF-JC-binding site are boxed.
DNA-binding domain that interacts with the 39 half site(B) Effect of mutations on NF-JC binding. Gel mobility shift assays
of the binding of K46R nuclear extract to the wild-type JC, the M1 of the recognition motif (Czerny et al., 1993). Since muta-
mutant JC, and the M2 mutant JC oligonucleotides described in tions in the 39 half site in the J chain promoter abrogate
Figure 4A. BSAP binding (Figures 4A and 4B), the shorter BSAP
(C) Inhibition of NF-JC binding by anti-BSAP antibody. Gel mobility
cDNA species was considered to encode a nonfunc-shift assays of the binding of K46R and S194 nuclear extracts to
tional product, even if it were translated into protein.the JC oligonucleotide in the presence of preimmune serum (pre-I)
The longer, functional BSAP cDNA was quantitatedor anti–human BSAP antiserum (I).
by two different procedures. In one, the cDNA products
were isolated by polyacrylamide gel electrophoresis andDNA-binding domain of human BSAP inhibited the rec-
stained with SYBR green, and the dye uptake was mea-ognition of the JC motif by the NF-JC protein endoge-
sured by use of the fluorimager. In the second, the sam-nously produced by the mature B cell line, K46R, and
ples were analyzed by Southern blotting with a knownby the plasmacytoma cell line, S194 (Figure 4C). The
BSAP cDNA fragment as probe, and the extent of hybrid-sum of these findings strongly indicated that NF-JC is
ization was determined by use of a phosphorimagerBSAP, and it will be referred to as such hereafter.
(Figure 5). The latter procedure also served to ascertain
the specificity of the cDNA product. Tubulin cDNA wasRegulation of BSAP Expression by IL-2
amplified and quantitated from each RNA preparation toPrevious analyses of BCL1 cells had shown that IL-2
treatment induces a progressive decrease in BSAP bind- correct for variability in RNA recovery and RT efficiency
BSAP Repression of the J Chain Gene
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Table 1. IL-2-Induced Down-Regulation of BSAP RNA and
BSAP Protein Expression in BCL1 Cells
Days after
IL-2 RNA Protein JC-Bound
Treatment Levelsa Levelsb Proteinc
Untreatedd 100 100 100
3 60 6 13e 55 56
6 23 6 11 37 29
a BSAP RNA values were normalized to the tubulin content of the
samples and expressed as a percentage of the values obtained
from untreated cells at days 3 and 6.
b Western blot staining was quantitated by densitometer and ex-
pressed as described in (a).
Figure 6. Linked Promoter Analyses of the JC Elementc Data are taken from McFadden and Koshland (1991).
d Cultured for 3 or 6 days without IL-2. Constructs containing four copies of JC wild-type or mutant M1
e Standard error of the mean (SEM) calculated from at least three oligomers were assayed for CAT activity in J chain–silent PD31 pre-
independent determinations. B cells and in J chain–expressing S194 myeloma cells. CAT activity
is expressed relative to the value obtained with the g-fibrinogen
promoter alone, which was set to 1.0. The values given represent
the average of at least three independent duplicate determinations,
and the calculated SEMs are represented by the error bars.(Figure 5). The normalized BSAP values obtained
showed that the IL-2 induces a down-regulation of BSAP
RNA (Table 1). In BCL1 cells, the level was reduced to
60% by day 3 and 23% by day 6 of IL-2 treatment. J chain gene, particularly at the very low levels of the
The IL-2-induced decrease in BSAP RNA content was factor observed in S194 nuclear extracts (Figures 2A
reflected in the nuclear levels of BSAP protein, as deter- and 4B). To determine that the repressive activity ob-
mined by Western blotting (Figure 5), and paralleled served was not an artifact of the oligomer constructs,
the pattern of decrease previously observed in BSAP we examined the function of a single JC element in
binding to the JC motif (Table 1). the context of J chain promoter sequences. For these
analyses, the following sequences were inserted into the
Analyses of In Vivo BSAP Function pg42CassI vector upstream of the minimal g-fibrinogen
The deletion analyses of the J chain promoter hypersen- promoter: the J2 fragment containing the JC element
sitive site indicated that BSAP functions as a transcrip- (2168 to 284); the J1 fragment containing the positive
tional repressor. Confirming evidence was obtained by regulatory elements, JA and JB (283 to 29); and a J1–J2
examining the activity of the JC element in the context fragment (2168 to 29) containing all three elements.
of a heterologous promoter. The construct used, pg42 Transfection of the J2 construct into J chain–
CassI, contained a truncated rat g-fibrinogen promoter expressing S194 cells confirmed the results obtained
placed upstream of the CAT gene (Durand et al., 1987). with the JC tetramers. The J2 fragment containing a
Control experiments showed that this construct pro- single JC site was found to be strongly repressive, in-
vided a low basal level of CAT expression in J chain– ducing a 9- to 10-fold decrease in CAT expression (Fig-
expressing myeloma lines, but not in J chain–silent B ure 7A). Two different criteria were used to ascertain
cell lines. An equivalent level was achieved in J chain– that the repression was mediated by BSAP binding to
silent B cells, however, by inserting an immunoglobulin the JC site. First, the M1 and M2 4 bp scrambles that
m heavy chain enhancer sequence in 39 to 59 orientation were known to abrogate BSAP binding (Figure 4B) were
downstream of the CAT gene. introduced into the J2 fragment. Analyses of the re-
For the JC functional assays, four copies of wild-type sulting constructs showed that the mutations abolished
or mutant JC oligonucleotide were cloned into the the repressive activity of the J2 fragment, restoring CAT
pg42CassI vector, and the resulting constructs were expression to that of the heterologous promoter control
transfected into J chain–silent PD31 pre-B cells and J (Figure 7A). Second, the activity of the J2 construct
chain–expressing S194 myeloma cells. Analyses of CAT was examined in MOPC315 cells, which do not express
expression showed that the wild-type tetramer con- detectable amounts of BSAP (Neurathet al., 1994). Com-
structs were repressive in both cell types, reducing CAT pared with its effect in S194 cells, the J2 fragment was
synthesis 5-fold in PD31 cells and 9-fold in S194 cells only minorly repressive in MOPC315 cells (Figure 7A),
(Figure 6). Moreover, the repression was shown to be reducing the transcriptional activity of the g-fibrinogen
BSAP specific in both cell lines. Thus, a tetramer con- promoter by one third. This small amount of repression
struct containing the M1 4 bp substitution that abro- may have reflected the activity of BSAP levels too low
gated BSAP binding (Figures 4A and 4B) had no repres- to be detected by gel mobility shift or RNase protection
sive activity in PD31 cells and even induced a 2- to assays.
3-fold increase in CAT activity in S194 cells. Transfection of the J1–J2 fragment into S194 cells,
however, gave very different results; the J1–J2 fragment
induced a 3-fold increase in CAT synthesis, comparedBSAP Expression in Early and Late Plasma Cells
The finding that the JC tetramer construct was strongly with the 9- to 10-fold decrease induced by the J2 frag-
ment alone (Figure 7B). Nevertheless, BSAP continuedrepressive in the J chain–positive S194 cell line was
surprising. It was not expected that BSAP would con- to bind to the J1–J2 fragment and exert some repres-
sion. The evidence was obtained by introducing the M1tinue to function as a repressor in cells transcribing the
Immunity
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pg42CassI vector and a J promoter vector lacking the
JC sequence, to almost the same extent as it inhibited
the CAT activity of the J chain reporter constructs.
Assays of stable BSAP transfectants, however, gave
clear-cut results (Figure 8). Of 15 G418-resistant clones
randomly selected for analysis,11 were found toexpress
recombinant BSAP transcripts, as judged by RT–PCR,
and to synthesize BSAP factor, as judged by gel shift
assays (data not shown). RNA was extracted from the
cloned cells and analyzed on Northern blots by succes-
sive hybridization with J chain, BSAP, and tubulin
probes. It was evident from inspection of the blots (Fig-
ure 8A) that the levels of J chain RNA were significantly
lower in the BSAP transfectants than in untransfected
S194 cells. Control experiments excluded the possibility
that the decrease was effected by the expression vector
itself (Figure 8B). In cells stably transfected with the
BCMGSNeo vector or in BSAP transfectants that failed
to express BSAP RNA, the levels of J chain RNA re-
mained equivalent to that present in wild-type S194
cells. Lysates were also prepared from transfectant and
control clones and examined for J chain protein by
Western blotting. As expected, the levels of intracellular
J chain were decreased in the BSAP transfectants to
the same extent as the levels of J chain RNA (data not
shown).
The extent of J chain RNA suppression was quanti-
tated by scanning the membranes with a phosphorim-
Figure 7. Linked Promoter Analyses of BSAP Function in J Chain– ager and correcting the J chain data for differences
Expressing Plasmacytomas in tubulin content among the RNA preparations. The
(A) Repressive activity of the J2 promoter fragment in plasmacyto- normalized values obtained (Figure 8A) showed that
mas. Constructs containing a single copy of the J2 fragment (2168
BSAP overexpression effected a 2- to 7-fold reductionto 284) or the J2 fragment containing the M1 and M2 4 bp substitu-
in J chain RNA content. The degree of suppression intions were assayed for CAT activity in J chain–expressing S194 and
each transfectant was reproducible; for example, fourMOPC315 plasmacytoma cells.
independent assays of clones Tf4 and Tf5 gave J chain(B) Overriding of JC repressive activity by downstream positive-
acting elements. Constructs with single copies of the J2 promoter values relative to wild type of 0.13 and 0.27, with stan-
fragment (2168 to 284), the J1 promoter fragment (283 to 29), the dard errors of the mean of 0.031 and 0.039, respectively.
J1–J2 fragment (2168 to 29), or the J1–J2 fragment containing the 4 The different degrees of suppression among the trans-
bp M1 and M2 substitutions were assayed for CAT activity following fectants correlated roughly with differences in BSAP
transfection into S194 cells. In (A) and (B), CAT activity is expressed
RNA content; clones with a 4- to 7-fold decrease in Jrelative to the value obtained with the g-fibrinogen promoter alone,
chain RNA contained approximately twice the levels ofwhich was set to 1.0. All values are the mean of at least three
BSAP RNA as clones with a 1.5- to 2-fold decrease. Theindependent duplicate determinations with the SEMs indicated by
the error bars. lack of a perfect correlation suggested that factors in
addition to BSAP concentration, e.g., differences in the
concentrations of NF-JA or PU.1, could influence the
and M2 mutations into the JC site of J1–J2 sequence. levels of J chain RNA in the individual clones.
The abrogation of BSAP binding resulted in an 8-fold The analyses of S194 cellsoverexpressing BSAP clari-
increase in CAT activity, 2.5 times that achieved by the fied several aspects of BSAP action. The observed
wild-type J1–J2 sequence and equivalent to that down-regulation of J chain RNA provided direct in vivo
achieved by the J1 fragment alone (Figure 7B). Thus, evidence that BSAP functions as a repressor of J chain
BSAP was found to function as a repressor of J chain promoter activity. The fact that the down-regulation was
gene transcription even at the very low levels seen in achieved by overexpressing BSAP in cells actively syn-
S194 plasmacytoma cells, but in these cells the repres- thesizing J chain RNA showed that BSAP repressor ac-
sion could be overridden by the positive activity of NF- tivity is concentration dependent. In view of these find-
JA and PU.1 factors bound to downstream J1 motifs. ings, it is likely that one function of the IL-2 signal
delivered during a primary immune response is to re-
Overexpression of BSAP in Plasma Cells duce the BSAP concentration to a low enough level to
The results of the J1–J2 analyses suggested that BSAP allow the positive regulators of J chain gene expression
concentration is a determining factor in the control of to dominate.
J chain gene expression. To test this hypothesis, we
examined the effects of BSAP overexpression in S194 Discussion
cells by both transient and stable transfection. Assays
of transiently transfected BSAP activity were inconclu- In the present study, the BSAP transcription factor was
sive. The BSAP expression vector was found to inhibit identified as a critical regulator of J chain gene expres-
sion. It mediates the silencing of the gene during thethe CAT activity of cotransfected control plasmids, the
BSAP Repression of the J Chain Gene
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Figure 8. Effect of BSAP Overexpression in
S194 Plasmacytoma Cells
Northern blot analyses of the J chain,
transfected BSAP, and tubulin transcripts in
(A) wild-type S194 cells and five randomly
selected transfectants expressing recombi-
nant BSAP and (B) wild-type S194 cells and
representative clones of vector and nonex-
pressing BSAP transformants. The relative J
chain RNA values were determined from
phosphorimager measurements normalized
to the tubulin RNA content. WT, wild type; Tf,
transfected with BSAP expression vector; V,
transfected with vector alone.
antigen-independent stages and the initial antigen- In addition to delineating a repressor function of
BSAP, the present study demonstrated that the expres-dependent stage of B cell development. The evidence
for its silencing function is based on the following obser- sion of BSAP is regulated by IL-2. The evidence was
obtained by analyses of the IL-2-responsive presecretorvations. First, BSAP expression correlates inversely with
J chain expression. Second, BSAP binds specifically to line, BCL1. IL-2 stimulation of these cells induced a pro-
gressive down-regulation in BSAP RNA levels that corre-the negative regulatory JC motif in the J chain gene
promoter. Third, the JC motif functions as a transcrip- lated with decreased BSAP binding to the JC repressor
site and induction of J chain message (McFadden andtional repressor only in those B cell lines expressing
BSAP, and its repressive activity is relieved by mutations Koshland, 1991; this paper). The BCL1 system has also
been used to identify a second IL-2-responsive factor,in the JC motif that abrogate BSAP binding. Finally,
overexpression of BSAP in plasma cells represses high Blimp-1, which is a member of the zinc finger–containing
family of DNA-binding proteins (Turner et al., 1994).level transcription of the endogenous J chain gene.
The mechanism by which BSAP binding to the JC Transcripts of the Blimp-1 gene are rapidly induced by
IL-2 or IL-5 treatment of BCL1 cells (Turner et al., 1994)motif mediates repression of the J chain gene is not
obvious. The JC recognition site is located approxi- or by the addition of IL-2 and IL-5 to primary B cells
treated with lipopolysaccharide (LPS) and anti–m F(ab9)2mately 100 bp upstream from the J chain TATA box and
50 bpaway from the nearest positive regulatory element, (Schliephake and Schimpl, 1996), and their expression
leads to the induction of J chain message, high levelthe downstream JA motif. It seems unlikely that BSAP
could function at this distance by any of the common IgM secretion, and other markers associated with early
plasma cells. Similar changes can be induced by trans-repressor mechanisms, i.e., by competing with a posi-
tive regulatory factor for a similar or overlapping site fection of a Blimp-1 expression vector into BCL1 or naive
B cells, suggesting that Blimp-1, like BSAP, is a key(Harada et al., 1989; Jaynes and O’Farrell, 1988), by
interfering with the DNA binding properties or activation regulator in the differentiation of a mature B cell to an
antibody secretor. Although BSAP and Blimp-1 havefunction of a transcriptional activator (Benezra et al.,
1990; Ron and Habener, 1992), or by directly preventing been identified as targets of IL-2 regulation, the mecha-
nism by which IL-2 down-regulates BSAP expressionthe formation of a transcription-competent RNA poly-
merase II complex (Gomez-Cuadrado et al., 1992; Inos- on the one hand, and up-regulates Blimp-1 expression
on the other, remains to be determined. The signal(s)troza et al., 1992). Bending of the J chain promoter DNA
downstream of the JC element, however, could serve could operate by controlling transcription initiation, tran-
script processing, RNA stabilization, or a combinationto bring BSAP within operating distance and allow it to
function as a repressor, perhaps by interacting with a of these mechanisms. In the case of BSAP, the finding of
an isoform lacking a portion of the DNA-binding domaintranscription complex subunit or by preventing access
of NF-JA or PU.1 to their respective binding sites (Giese raises the possibility that down-regulation may be
achieved by alternative processing.et al., 1992). Alternatively, BSAP could function from its
upstream location by facilitating the stable positioning The pattern of BSAP binding in cell lines representa-
tive of successive stages in B cell differentiation (Figureof a nucleosome over target positive regulatory motifs
in the promoter (Roth et al., 1992). A blockage-type 2A) suggests that BSAP expression is constitutive until
the early stages of an immune response. Then, a regula-mechanism is supported by in vivo footprinting of the
39 heavy chain enhancer (Neurath et al., 1995a). BSAP tory signal is initiated when the IL-2, and probably also
the IL-5 (Matsui et al., 1989; McFadden and Koshland,binding to its enhancer site was found to correlate in-
versely with the binding 50 bp downstream of an Ets- 1991), secreted by antigen-activated T cells binds to
high affinity IL-2 and IL-5 receptors induced on antigen-like factor that positively regulates enhancer activity.
Interestingly, the J chain promoter has a similar arrange- activated B cells. The signal(s) generated causes a pro-
gressive decrease in BSAP RNA accumulation that ex-ment of negative- and positive-acting motifs; the BSAP-
binding site is located 50 bp upstream of the NF-JA and tends from the presecretor immunoblast through the
plasma cell stages. Contrary to a previous report (Adams60 bp upstream of the Ets PU.1-binding sites.
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BSAP protein for analysis, BSAP cDNA was isolated from the BSAP-et al., 1992) fully mature S194 plasmacytoma cells were
BCMGSNeo plasmid by XhoI–NotI cleavage, the 59 end was bluntfound to maintain a low level of BSAP RNA, suggesting
ended, and the resulting fragment was cloned into the pcDNAI (In-that BSAP may continue to be synthesized at a basal
vitrogen) polylinker by use of a blunt-ended HindIII and a NotI site.
rate even at the terminal stage of B cell differentiation. The plasmid was linearized with XbaI, transcribed in vitro with T7
Moreover, the small amount present in plasma cells re- RNA polymerase, and translated in vitro with a rabbit reticulocyte
lysate (Promega) according to the protocolssuggested by the manu-mains fully functional, as judged in this report by mea-
facturer.surements of its repressive activity.
For gel mobility shift assays, the specific oligonucleotides wereThe characterization of BSAP expression during anti-
end labeled with [a-32P]dCTP and Klenow enzyme (Sambrook etgen-driven B cell differentiation has considerable impli-
al., 1989). The binding reactions with crude nuclear extracts were
cations for understanding the dual regulatory functions performed as described previously (McFadden and Koshland, 1991)
of BSAP. IL-2-induced down-regulation of BSAP ex- using 8–10 mg of extract, 4–6 mg of poly(dI–dC) nonspecific competi-
tor, and 104 cpm (0.1–1.0 ng) of probe. The binding reaction with inpression is consistent with a loss of function at BSAP
vitro synthesized BSAP used 5 ml of reticulocyte lysate and 4 mg ofpositive regulatory sites, as is observed in the turning
nonspecific competitor. For the antibody blocking assays, crudeoff of CD19 or Blk Src kinase transcripts. IL-2-induced
nuclear extracts were preincubated with 2 ml of a 1:10 dilution ofdown-regulation of BSAP expression is also consistent
either rabbit preimmune sera or rabbit anti–human BSAP antiserum
with a gain of function at negative regulatory sites, as directed against the DNA-binding paired domain. In each case the
is observed with BSAP release from the 39 heavy chain protein–DNA complexes formed were resolved from free probe by
electrophoresis through glycerol-containing 5% polyacrylamideenhancer and the J chain promoter sites. On the other
gels (29:1) containing 0.253 TBE buffer.hand, it is difficult to reconcile a decrease in BSAP ex-
pression with a gain in positive function, such as BSAP
Footprinting Assaysactivation of B cell proliferation (Wakatsuki et al., 1994)
Methylation protection footprinting was performed with crude nu-
and germline e transcription (Liao et al., 1994). In particu- clear extracts from the mature B cell line, K46R; 50 mg of nuclear
lar, the germline e transcription that precedes the switch protein was incubated for 15 min at 08C with 2 mg of poly(dI–dC)
to IgE synthesis is known to occur relatively late in a B and 106 cpm of DNA probe. Dimethylsulfate (0.5 ml) was added
for 45 s and quenched by the addition of dithiothreitol to a finalcell primary response and to require an active 39 heavy
concentration of 23 mM. The remaining steps in the assay, isolationchain enhancer released from BSAP repression (Cogne
and sequencing of free and protein-bound DNA, were performedet al., 1994).
according to the standard protocol for methylation interference foot-
The analyses of J chain gene activation presented printing (Ausubel et al., 1987). The probe was a 100 bp XbaI–HindIII
here suggest that the different regulatory activities of fragment containing the J chain sequence 2168 to 284 that was
BSAP may be accounted for by competition among the end labeled on the top or bottom strand.
BSAP sites for the low levels of factor expressed at the
Plasmid Constructions for Linked Promoter Analysesearly plasma cell stage. Thus, IL-2 may regulate BSAP
In the pg42CassI vector (Durand et al., 1987) the CAT gene is underconcentration so that enough BSAP can bind to the
control of a truncated g-fibrinogen promoter (254 to 136) that in-LPS/IL-4-inducible Ie promoter to generate germline e
cludes a TATA box and a single Sp1-binding site. Fragments from
transcripts, but not enough interacts at the J chain pro- the J chain promoter (J1, base pairs 283 to 29; J2, base pairs
moter or 39 heavy chain enhancer sites to block the 2168 to 284; J1–J2, base pairs 2168 to 29) and oligonucleotides
dominating effects of positive regulatory factors binding representing the JC elementand mutant JC sequences were synthe-
sized with XbaI linkersand inserted either singly or in multiple copiesdownstream. This model is supported by the results of
into the polylinker upstream of the g-fibrinogen promoter. All con-BSAP overexpression in plasma cells expressing high
structs were sequenced to determine oligomer copy number andlevels of J chain. By raising the BSAP concentration in
orientation.
these cells, it was possible to achieve enough BSAP Mutagenesis of the pg42CassI plasmid containing either the J2
binding to the J chain promoter to reverse the positive or the J1–J2 sequence was performed with the Transformer site-
activity of NF-JA and PU.1 and thus significantly reduce directed mutagenesis kit (Clontech Laboratories). Two primer
sequences, 59-CTTTCCAGTGTAGACGTCAGTTCAAACCTG-39 andthe expression of the J chain gene.
59-CTTTCCAGTGTAGGTCACAGTTCAAACCTG-39, were used to in-
troduce each 4 bp change in the JC site (JCM1 and JCM2 mutants,
respectively), whereas a second primer sequence, 59-GCCCCCGTTExperimental Procedures
TTCACGATGGGCAAATATTA-39, was used to introduce a single
base pair change in the NcoI site in the CAT gene. The latter changeCell Culture
eliminated cleavage by NcoI without altering the CAT amino acidThe cell lines representative of pre-B, immature B, and mature B
sequence and thus provided a ready screen for mutant constructs.stages of development were maintained in RPMI 1640 supple-
The selected plasmid was sequenced to verify the base substitu-mented with 10% fetal bovine serum, 2 mM L-glutamine, 50 mM
tions.2-mercaptoethanol, 100 U of penicillin per milliliter, and 100 mg of
streptomycin per milliliter.The various myeloma andhybridoma lines
Transfectionswere cultured in Dulbecco’s modified Eagle’s medium supple-
Transient transfections of S194 myeloma cells and PD31 pre-B cellsmented as described above.
were performed by the DEAE–dextran technique (Grosschedl and
Baltimore, 1985) and transfections of MOPC315 myeloma cells by
electroporation (Neurath et al., 1994). In each case, 107 cells inPreparation and Assay of Nuclear Proteins
Large-scale extracts were prepared from 109 cells by the detergent logarithmic growth phase were transfected with 9 mg of supercoiled
test plasmid or a combination of plasmids. Cell extracts were pre-lysis method of Peterson et al. (1986) as modified by Lansford et
al. (1992). All buffers contained the following cocktail of protease pared 44–48 hr after transfection and assayed for CAT activity (Lans-
ford et al., 1992).inhibitors: 0.5 nM phenylmethylsulfonylfluoride, 0.5 mM dithiothrei-
tol, 0.5 mM Na2S2O5, aprotinin (10 U/ml), leupeptin (5 mg/ml), and For the generation of stable transfectants, 8 mg of the BSAP-
BCMGSNeo construct (Neurath et al., 1994) or the BCMGSNeo vec-pepstatin A (5 mg/ml). Mini-extracts were prepared from 107 cells
as described previously (McFadden and Koshland, 1991). To obtain tor were introduced into S194 cells by electroporation; 1.5 3 107
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